Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

Stopped early · Phase 4

Conditions studied: Psoriasis

In brief

This study will evaluate the efficacy of etanercept in patients with plaque psoriasis who have lost a satisfactory response to adalimumab.

Key facts

Study ID

NCT01543204

Run by

Amgen

People needed

64

Starts

2012-02-01

Expected to finish

2015-05-29

Last updated by the study team

2017-12-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Moderate to severe plaque psoriasis
• Loss of satisfactory response to adalimumab
• Currently receiving or recently discontinued treatment with adalimumab

You may not qualify if…

• Active skin conditions that would interfere with evaluations of the effect of investigational product on psoriasis
• Serious medical conditions

Where it is running

• Research Site — Birmingham, Alabama, United States
• Research Site — Mobile, Alabama, United States
• Research Site — Phoenix, Arizona, United States
• Research Site — Bakersfield, California, United States
• Research Site — Encino, California, United States
• Research Site — Irvine, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Sacramento, California, United States
• Research Site — San Francisco, California, United States
• Research Site — San Ramon, California, United States
• Research Site — Santa Monica, California, United States
• Research Site — Denver, Colorado, United States
• Research Site — Farmington, Connecticut, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — St. Petersburg, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Macon, Georgia, United States
• Research Site — Skokie, Illinois, United States
• Research Site — New Albany, Indiana, United States
• Research Site — Plainfield, Indiana, United States
• Research Site — Louisville, Kentucky, United States
• Research Site — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.